{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:23:14Z","timestamp":1790230994318,"version":"4.1.0"},"reference-count":235,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.peptides.2020.170402","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T15:22:29Z","timestamp":1598973749000},"page":"170402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Peptides to combat viral infectious diseases"],"prefix":"10.1016","volume":"134","author":[{"given":"Shams","family":"Al-Azzam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsha","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joey Paolo","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Afshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Rr-15","key":"10.1016\/j.peptides.2020.170402_bib0005","first-page":"1","article-title":"Preventing emerging infectious diseases: a strategy for the 21st century. Overview of the updated CDC plan","volume":"47","year":"1998","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.peptides.2020.170402_bib0010","year":"2020","journal-title":"JHUoMCr center, Journal"},{"key":"10.1016\/j.peptides.2020.170402_bib0015","unstructured":"1.0 AF. http:\/\/ddg-pharmfac.net\/AllergenFP\/."},{"key":"10.1016\/j.peptides.2020.170402_bib0020","series-title":"2.0 Av. Bioinformatics Tool For Allergenicity Prediction","year":"2020"},{"key":"10.1016\/j.peptides.2020.170402_bib0025","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.3762\/bjnano.10.104","article-title":"Enhanced inhibition of influenza virus infection by peptide-noble-metal nanoparticle conjugates","volume":"10","author":"Alghrair","year":"2019","journal-title":"Beilstein J. Nanotechnol."},{"issue":"4","key":"10.1016\/j.peptides.2020.170402_bib0030","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.immuni.2020.03.007","article-title":"SARS-CoV-2 vaccines: status report","volume":"52","author":"Amanat","year":"2020","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1179\/2047773212Y.0000000004","article-title":"Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus","volume":"106","author":"Ammendolia","year":"2012","journal-title":"Pathog. Glob. Health"},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000197314","article-title":"Influenza virus","volume":"36","author":"Arbeitskreis Blut","year":"2009","journal-title":"Transfus Med. Hemother."},{"issue":"4","key":"10.1016\/j.peptides.2020.170402_bib0045","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.dsx.2020.04.020","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response","volume":"14","author":"Ysrafil","year":"2020","journal-title":"Diabetes Metab. Syndr."},{"issue":"44","key":"10.1016\/j.peptides.2020.170402_bib0050","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1016\/j.vaccine.2014.08.031","article-title":"Priming by a novel universal influenza vaccine (multimeric-001)-a gateway for improving immune response in the elderly population","volume":"32","author":"Atsmon","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.peptides.2020.170402_bib0055","series-title":"Understanding The Mechanism Of Action Of Flufirvitide-3 A. Peptide Based Inhibitor Of Influenza Virus","author":"Badani","year":"2014"},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib0060","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41598-017-18863-0","article-title":"Functional antibody response against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 vaccine trials","volume":"8","author":"Balasubramanian","year":"2018","journal-title":"Sci. Rep."},{"issue":"10143","key":"10.1016\/j.peptides.2020.170402_bib0065","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0140-6736(18)31364-3","article-title":"Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1\/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)","volume":"392","author":"Barouch","year":"2018","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.peptides.2020.170402_bib0070","doi-asserted-by":"crossref","first-page":"9786","DOI":"10.1128\/JVI.79.15.9786-9798.2005","article-title":"Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition","volume":"79","author":"Barrera","year":"2005","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.peptides.2020.170402_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195744","article-title":"Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women","volume":"13","author":"B\u00e1rtolo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2020.170402_bib0080","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.17.1.657","article-title":"Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease","volume":"17","author":"Berger","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.peptides.2020.170402_bib0085","series-title":"NetCTL 1.2 Server","author":"Bioinformatics","year":"2017"},{"issue":"8","key":"10.1016\/j.peptides.2020.170402_bib0090","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1021\/acs.molpharmaceut.7b00155","article-title":"Design of HIV coreceptor derived peptides that inhibit viral entry at submicromolar concentrations","volume":"14","author":"Bobyk","year":"2017","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.peptides.2020.170402_bib0095","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection","volume":"81","author":"Boni","year":"2007","journal-title":"J. Virol."},{"issue":"21","key":"10.1016\/j.peptides.2020.170402_bib0100","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1001\/jama.289.21.JOC30885","article-title":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area","volume":"289","author":"Booth","year":"2003","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.peptides.2020.170402_bib0105","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/QAD.0b013e32835edc1d","article-title":"An ancestral HIV-2\/simian immunodeficiency virus peptide with potent HIV-1 and HIV-2 fusion inhibitor activity","volume":"27","author":"Borrego","year":"2013","journal-title":"Aids"},{"issue":"2","key":"10.1016\/j.peptides.2020.170402_bib0110","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1128\/AAC.01152-12","article-title":"A rationally engineered anti-HIV peptide fusion inhibitor with greatly reduced immunogenicity","volume":"57","author":"Brauer","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Web Server issue","key":"10.1016\/j.peptides.2020.170402_bib0115","doi-asserted-by":"crossref","first-page":"W349","DOI":"10.1093\/nar\/gkt381","article-title":"Scalable web services for the PSIPRED protein analysis workbench","volume":"41","author":"Buchan","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.peptides.2020.170402_bib0120","doi-asserted-by":"crossref","first-page":"W402","DOI":"10.1093\/nar\/gkz297","article-title":"The PSIPRED protein analysis workbench: 20 years on","volume":"47","author":"Buchan","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.peptides.2020.170402_bib0125","series-title":"A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Corona Virus Disease 2019 (COVID-19) medRxiv","author":"Cai","year":"2020"},{"issue":"2","key":"10.1016\/j.peptides.2020.170402_bib0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171567","article-title":"The improved efficacy of sifuvirtide compared with enfuvirtide might be related to its selectivity for the rigid biomembrane, as determined through surface plasmon resonance","volume":"12","author":"Cao","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2020.170402_bib0135","series-title":"What Are the Benefits of Flu Vaccination?","year":"2018"},{"key":"10.1016\/j.peptides.2020.170402_bib0140","series-title":"Influenza Antiviral Drug Resistance","year":"2019"},{"key":"10.1016\/j.peptides.2020.170402_bib0145","series-title":"CDC Seasonal Flu Vaccine Effectiveness Studies, 2004-2019","year":"2020"},{"key":"10.1016\/j.peptides.2020.170402_bib0150","series-title":"Estimated Influenza Illnesses, Medical Visits, Hospitalizations, and Deaths in the United States \u2014 2018\u20132019 Influenza Season","year":"2020"},{"key":"10.1016\/j.peptides.2020.170402_bib0155","series-title":"Influenza A Subtypes and the Species Affected","year":"2020"},{"issue":"5","key":"10.1016\/j.peptides.2020.170402_bib0160","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0092-8674(00)81430-0","article-title":"HIV entry and its inhibition","volume":"93","author":"Chan","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.peptides.2020.170402_bib0165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.antiviral.2018.05.005","article-title":"Innovation and trends in the development and approval of antiviral medicines: 1987-2017 and beyond","volume":"155","author":"Chaudhuri","year":"2018","journal-title":"Antiviral Res."},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib0170","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1039\/C9MD00473D","article-title":"Discovery and characterization of a novel peptide inhibitor against influenza neuraminidase","volume":"11","author":"Chen","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.peptides.2020.170402_bib0175","article-title":"Structure analysis of the receptor binding of 2019-nCoV","author":"Chen","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.peptides.2020.170402_bib0180","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1128\/CMR.00023-07","article-title":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection","volume":"20","author":"Cheng","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"issue":"7","key":"10.1016\/j.peptides.2020.170402_bib0185","doi-asserted-by":"crossref","DOI":"10.3390\/v12070731","article-title":"In silico prediction of human leukocytes antigen (HLA) class II binding hepatitis B virus (HBV) peptides in Botswana","volume":"12","author":"Choga","year":"2020","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.peptides.2020.170402_bib0190","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00288-17","article-title":"A lipopeptide HIV-1\/2 fusion inhibitor with highly potent in vitro, ex vivo, and in vivo antiviral activity","volume":"91","author":"Chong","year":"2017","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib0195","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0006-291X(03)01342-1","article-title":"Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS","volume":"308","author":"Chou","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2020.170402_bib0200","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ebiom.2016.06.037","article-title":"Tyrosine-sulfated V2 peptides inhibit HIV-1 infection via coreceptor mimicry","volume":"10","author":"Cimbro","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.peptides.2020.170402_bib0205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.peptides.2014.04.019","article-title":"Potential therapeutic applications of multifunctional host-defense peptides from frog skin as anti-cancer, anti-viral, immunomodulatory, and anti-diabetic agents","volume":"57","author":"Conlon","year":"2014","journal-title":"Peptides"},{"issue":"6","key":"10.1016\/j.peptides.2020.170402_bib0210","first-page":"452","article-title":"Management and prevention strategies for respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a review of evidence-based practice interventions","volume":"29","author":"Cooper","year":"2003","journal-title":"Pediatr. Nurs."},{"key":"10.1016\/j.peptides.2020.170402_bib0215","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ebiom.2016.07.023","article-title":"Immunotherapy with the PreS-based grass pollen allergy vaccine BM32 induces antibody responses protecting against hepatitis B infection","volume":"11","author":"Cornelius","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.peptides.2020.170402_bib0220","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-61779-379-0_16","article-title":"mRNA display-based selections using synthetic peptide and natural protein libraries","volume":"805","author":"Cotten","year":"2012","journal-title":"Methods Mol. Biol."},{"issue":"Suppl 1","key":"10.1016\/j.peptides.2020.170402_bib0225","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S0168-8278(03)00154-5","article-title":"Interferon-alpha for HBeAg-positive chronic hepatitis B","volume":"39","author":"Craxi","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.peptides.2020.170402_bib0230","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","author":"Gordon","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.peptides.2020.170402_bib0235","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1586\/14787210.4.2.291","article-title":"Potential antivirals and antiviral strategies against SARS coronavirus infections","volume":"4","author":"De Clercq","year":"2006","journal-title":"Expert Rev. Anti Infect Ther."},{"key":"10.1016\/j.peptides.2020.170402_bib0240","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/148317","article-title":"A recombinant multiepitope protein for hepatitis B diagnosis","volume":"2013","author":"de Souza","year":"2013","journal-title":"Biomed Res. Int."},{"issue":"8","key":"10.1016\/j.peptides.2020.170402_bib0245","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: recent insights into emerging coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"issue":"8","key":"10.1016\/j.peptides.2020.170402_bib0250","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1128\/JVI.01270-06","article-title":"Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site","volume":"81","author":"Deng","year":"2007","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.peptides.2020.170402_bib0255","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25506","article-title":"The search for an HIV vaccine, the journey continues","volume":"23","author":"Dieffenbach","year":"2020","journal-title":"J. Int. AIDS Soc."},{"issue":"18","key":"10.1016\/j.peptides.2020.170402_bib0260","doi-asserted-by":"crossref","first-page":"15076","DOI":"10.1074\/jbc.M111.332361","article-title":"Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1","volume":"287","author":"Dogo-Isonagie","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib0265","doi-asserted-by":"crossref","first-page":"15307","DOI":"10.1038\/s41598-017-15338-0","article-title":"Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP","volume":"7","author":"Donkers","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.peptides.2020.170402_bib0270","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1128\/AAC.49.11.4721-4732.2005","article-title":"Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity","volume":"49","author":"Dorr","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.peptides.2020.170402_bib0275","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.4049\/jimmunol.1101335","article-title":"Hapivirins and diprovirins: novel \u03b8-defensin analogs with potent activity against influenza a virus","volume":"188","author":"Doss","year":"2012","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.peptides.2020.170402_bib0280","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/infdis\/jix614","article-title":"HBV-derived synthetic long peptide can boost CD4+ and CD8+ T-cell responses in chronic HBV patients Ex vivo","volume":"217","author":"Dou","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.peptides.2020.170402_bib0285","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinf."},{"issue":"20","key":"10.1016\/j.peptides.2020.170402_bib0290","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa030747","article-title":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","volume":"348","author":"Drosten","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.peptides.2020.170402_bib0295","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.peptides.2004.06.018","article-title":"Polyprotein cleavage mechanism of SARS CoV mpro and chemical modification of the octapeptide","volume":"25","author":"Du","year":"2004","journal-title":"Peptides"},{"issue":"11","key":"10.1016\/j.peptides.2020.170402_bib0300","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1128\/JVI.02094-05","article-title":"Sequential immunization with V3 peptides from primary human immunodeficiency virus type 1 produces cross-neutralizing antibodies against primary isolates with a matching narrow-neutralization sequence motif","volume":"80","author":"Eda","year":"2006","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.peptides.2020.170402_bib0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065588","article-title":"Increased expression of Gp96 by HBx-induced NF-kappaB activation feedback enhances hepatitis B virus production","volume":"8","author":"Fan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2020.170402_bib0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","article-title":"Coronaviruses: an overview of their replication and pathogenesis","volume":"1282","author":"Fehr","year":"2015","journal-title":"Methods Mol. Biol."},{"issue":"Web Server issue","key":"10.1016\/j.peptides.2020.170402_bib0315","doi-asserted-by":"crossref","first-page":"W182","DOI":"10.1093\/nar\/gkl189","article-title":"DiANNA 1.1: an extension of the DiANNA web server for ternary cysteine classification","volume":"34","author":"Ferre","year":"2006","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.peptides.2020.170402_bib0320","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/428404","article-title":"Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection","volume":"191","author":"Flynn","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib0325","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/gutjnl-2013-305707","article-title":"Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN","volume":"64","author":"Fontaine","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.peptides.2020.170402_bib0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.biochem.67.1.1","article-title":"HIV-1: fifteen proteins and an RNA","volume":"67","author":"Frankel","year":"1998","journal-title":"Annu. Rev. Biochem"},{"issue":"7","key":"10.1016\/j.peptides.2020.170402_bib0335","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"issue":"4","key":"10.1016\/j.peptides.2020.170402_bib0340","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.peptides.2005.09.006","article-title":"Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase","volume":"27","author":"Gan","year":"2006","journal-title":"Peptides"},{"issue":"13","key":"10.1016\/j.peptides.2020.170402_bib0345","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1093\/nar\/gkg563","article-title":"ExPASy: The proteomics server for in-depth protein knowledge and analysis","volume":"31","author":"Gasteiger","year":"2003","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.peptides.2020.170402_bib0350","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1039\/B919070H","article-title":"An electrochemical peptide-based biosensing platform for HIV detection","volume":"46","author":"Gerasimov","year":"2010","journal-title":"Chem. Commun. (Camb.)"},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib0355","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.gastro.2005.03.090","article-title":"Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes","volume":"129","author":"Glebe","year":"2005","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.peptides.2020.170402_bib0360","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.bbagen.2016.02.008","article-title":"Definition of an 18-mer synthetic peptide derived from the GB virus C E1 protein as a New HIV-1 entry inhibitor","volume":"1860","author":"G\u00f3mara","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.peptides.2020.170402_bib0365","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jviromet.2011.03.009","article-title":"The performance of the VIKIA(\u00ae) HIV1\/2 rapid test-evaluation of the reliability and sensitivity","volume":"173","author":"Gomes","year":"2011","journal-title":"J. Virol. Methods"},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib0370","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/rmv.483","article-title":"Mechanisms of action of ribavirin against distinct viruses","volume":"16","author":"Graci","year":"2006","journal-title":"Rev. Med. Virol."},{"issue":"2","key":"10.1016\/j.peptides.2020.170402_bib0375","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s12072-011-9261-3","article-title":"HBV life cycle and novel drug targets","volume":"5","author":"Grimm","year":"2011","journal-title":"Hepatol. Int."},{"issue":"3","key":"10.1016\/j.peptides.2020.170402_bib0380","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1128\/JVI.79.3.1613-1622.2005","article-title":"Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein","volume":"79","author":"Gripon","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.peptides.2020.170402_bib0385","first-page":"211","article-title":"Synthetic peptides as protein mimics","volume":"3","author":"Gro\u00df","year":"2015","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"Web Server issue","key":"10.1016\/j.peptides.2020.170402_bib0390","doi-asserted-by":"crossref","first-page":"W526","DOI":"10.1093\/nar\/gki376","article-title":"JCat: a novel tool to adapt codon usage of a target gene to its potential expression host","volume":"33","author":"Grote","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.peptides.2020.170402_bib0395","series-title":"Group I. Tools: Predicting Antigenic Peptides","year":"2020"},{"issue":"9403","key":"10.1016\/j.peptides.2020.170402_bib0400","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(03)15259-2","article-title":"Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome","volume":"363","author":"Guan","year":"2004","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.peptides.2020.170402_bib0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073957","article-title":"Open source drug Discovery C, et al. In silico approach for predicting toxicity of peptides and proteins","volume":"8","author":"Gupta","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.peptides.2020.170402_bib0410","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3390\/v4071144","article-title":"Influenza virus-mediated membrane fusion: determinants of hemagglutinin fusogenic activity and experimental approaches for assessing virus fusion","volume":"4","author":"Hamilton","year":"2012","journal-title":"Viruses"},{"issue":"20","key":"10.1016\/j.peptides.2020.170402_bib0415","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1021\/jm5007676","article-title":"Synthesis and influenza virus inhibitory activities of carbosilane dendrimers peripherally functionalized with hemagglutinin-binding peptide","volume":"57","author":"Hatano","year":"2014","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.peptides.2020.170402_bib0420","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/jgh.13175","article-title":"Early events in hepatitis B virus infection: from the cell surface to the nucleus","volume":"31","author":"Hayes","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"42","key":"10.1016\/j.peptides.2020.170402_bib0425","doi-asserted-by":"crossref","first-page":"16332","DOI":"10.1073\/pnas.0807335105","article-title":"Potent HIV fusion inhibitors against enfuvirtide-resistant HIV-1 strains","volume":"105","author":"He","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"17","key":"10.1016\/j.peptides.2020.170402_bib0430","doi-asserted-by":"crossref","first-page":"11126","DOI":"10.1074\/jbc.M800200200","article-title":"Design and evaluation of sifuvirtide, a novel HIV-1 fusion inhibitor","volume":"283","author":"He","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.peptides.2020.170402_bib0435","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/abbs\/gmu049","article-title":"Selection of HBV preS1-binding penta-peptides by phage display","volume":"46","author":"He","year":"2014","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"issue":"6","key":"10.1016\/j.peptides.2020.170402_bib0440","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.4049\/jimmunol.173.6.4050","article-title":"Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines","volume":"173","author":"He","year":"2004","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.peptides.2020.170402_bib0445","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/hep.510300208","article-title":"A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T cell vaccine study group","volume":"30","author":"Heathcote","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.peptides.2020.170402_bib0450","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.virol.2017.11.018","article-title":"a novel peptide-based vaccine candidate with protective efficacy against influenza a in a mouse model","volume":"515","author":"Herrera-Rodriguez","year":"2018","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.peptides.2020.170402_bib0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and Is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.peptides.2020.170402_bib0460","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrmicro1208","article-title":"Influenza: lessons from past pandemics, warnings from current incidents","volume":"3","author":"Horimoto","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.peptides.2020.170402_bib0465","doi-asserted-by":"crossref","DOI":"10.3390\/ph9030053","article-title":"The role of antimicrobial peptides in influenza virus infection and their potential as antiviral and immunomodulatory therapy","volume":"9","author":"Hsieh","year":"2016","journal-title":"Pharmaceuticals (Basel)"},{"issue":"11","key":"10.1016\/j.peptides.2020.170402_bib0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006698","article-title":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus","volume":"13","author":"Hu","year":"2017","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.peptides.2020.170402_bib0475","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1021\/cc0500607","article-title":"Screening and identification of linear B-cell epitopes and entry-blocking peptide of severe acute respiratory syndrome (SARS)-associated coronavirus using synthetic overlapping peptide library","volume":"7","author":"Hu","year":"2005","journal-title":"J. Comb. Chem."},{"issue":"5750","key":"10.1016\/j.peptides.2020.170402_bib0480","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1126\/science.1118398","article-title":"Structure of a V3-containing HIV-1 gp120 core","volume":"310","author":"Huang","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.peptides.2020.170402_bib0485","series-title":"Epitope Prediction","year":"2020"},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib0490","doi-asserted-by":"crossref","first-page":"vew014","DOI":"10.1093\/ve\/vew014","article-title":"Antiviral drug resistance as an adaptive process","volume":"2","author":"Irwin","year":"2016","journal-title":"Virus Evol."},{"issue":"2","key":"10.1016\/j.peptides.2020.170402_bib0495","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.contraception.2004.03.012","article-title":"HIV diagnostic tests: an overview","volume":"70","author":"Iweala","year":"2004","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.peptides.2020.170402_bib0500","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.antiviral.2010.04.011","article-title":"Characterization of HIV-1 resistance to a fusion inhibitor, N36, derived from the gp41 amino-terminal heptad repeat","volume":"87","author":"Izumi","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.peptides.2020.170402_bib0505","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2 - preliminary report","author":"Jackson","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.peptides.2020.170402_bib0510","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/ajhp\/61.12.1242","article-title":"Enfuvirtide: first fusion inhibitor for treatment of HIV infection","volume":"61","author":"Jamjian","year":"2004","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"7","key":"10.1016\/j.peptides.2020.170402_bib0515","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3201\/eid1107.050219","article-title":"SARS vaccine development","volume":"11","author":"Jiang","year":"2005","journal-title":"Emerg. Infect. Dis."},{"issue":"6442","key":"10.1016\/j.peptides.2020.170402_bib0520","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/365113a0","article-title":"HIV-1 inhibition by a peptide","volume":"365","author":"Jiang","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2020.170402_bib0525","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Jie Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"issue":"24","key":"10.1016\/j.peptides.2020.170402_bib0530","doi-asserted-by":"crossref","first-page":"11960","DOI":"10.1128\/JVI.01678-06","article-title":"Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells","volume":"80","author":"Jones","year":"2006","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.peptides.2020.170402_bib0535","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s13337-013-0162-z","article-title":"Multiple antigenic peptide (MAP): a synthetic peptide dendrimer for diagnostic, antiviral and vaccine strategies for emerging and re-emerging viral diseases","volume":"24","author":"Joshi","year":"2013","journal-title":"Indian J. Virol."},{"issue":"6362","key":"10.1016\/j.peptides.2020.170402_bib0540","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1126\/science.aan0516","article-title":"Potent peptidic fusion inhibitors of influenza virus","volume":"358","author":"Kadam","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.peptides.2020.170402_bib0545","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijbiomac.2019.07.024","article-title":"Development of multi-epitope driven subunit vaccine against fasciola gigantica using immunoinformatics approach","volume":"138","author":"Kalita","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.peptides.2020.170402_bib0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104236","article-title":"Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2","volume":"145","author":"Kalita","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.peptides.2020.170402_bib0555","first-page":"187","article-title":"Influenza treatment and prophylaxis with neuraminidase inhibitors: a review","volume":"6","author":"Kamali","year":"2013","journal-title":"Infect. Drug Resist."},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.resinv.2018.10.002","article-title":"Baloxavir heralds a new era in influenza virus biology","volume":"57","author":"Kikuchi","year":"2019","journal-title":"Respir. Investig."},{"issue":"33","key":"10.1016\/j.peptides.2020.170402_bib0565","doi-asserted-by":"crossref","first-page":"13797","DOI":"10.1073\/pnas.0906514106","article-title":"Peptides modulating conformational changes in secreted chaperones: from in silico design to preclinical proof of concept","volume":"106","author":"Kliger","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.peptides.2020.170402_bib0570","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1128\/JCM.00665-08","article-title":"Comparison of two rapid human immunodeficiency virus (HIV) assays, determine HIV-1\/2 and OraQuick advance rapid HIV-1\/2, for detection of recent HIV seroconversion","volume":"46","author":"Kshatriya","year":"2008","journal-title":"J. Clin. Microbiol."},{"issue":"6","key":"10.1016\/j.peptides.2020.170402_bib0575","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1615\/CritRevImmunol.2013007909","article-title":"Regulation of antiviral CD8 T-cell responses","volume":"33","author":"Kulinski","year":"2013","journal-title":"Crit. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.peptides.2020.170402_bib0580","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1073\/pnas.93.5.2186","article-title":"Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion","volume":"93","author":"Lambert","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib0585","first-page":"122","article-title":"Role of glycosaminoglycans for binding and infection of hepatitis B virus","volume":"10","author":"Leistner","year":"2008","journal-title":"Cell. Microbiol."},{"issue":"10","key":"10.1016\/j.peptides.2020.170402_bib0590","doi-asserted-by":"crossref","DOI":"10.3390\/md16100377","article-title":"a novel natural influenza a H1N1 virus neuraminidase inhibitory peptide derived from cod skin hydrolysates and its antiviral mechanism","volume":"16","author":"Li","year":"2018","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.peptides.2020.170402_bib0595","article-title":"Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2","author":"Li","year":"2020","journal-title":"bioRxiv"},{"issue":"4","key":"10.1016\/j.peptides.2020.170402_bib0600","article-title":"Blockage of conformational changes of heat shock protein gp96 on cell membrane by a alpha-helix peptide inhibits HER2 dimerization and signaling in breast cancer","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"issue":"9663","key":"10.1016\/j.peptides.2020.170402_bib0605","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib0610","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1039\/C5CC05684E","article-title":"Simple, rapid detection of influenza a (H1N1) viruses using a highly sensitive peptide-based molecular beacon","volume":"52","author":"Lim","year":"2016","journal-title":"Chem. Commun. (Camb.)"},{"issue":"7","key":"10.1016\/j.peptides.2020.170402_bib0615","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/135965350701200702","article-title":"Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine","volume":"12","author":"Lin","year":"2007","journal-title":"Antivir. Ther."},{"issue":"3","key":"10.1016\/j.peptides.2020.170402_bib0620","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.cr.7290158","article-title":"Identification of an epitope of SARS-coronavirus nucleocapsid protein","volume":"13","author":"Lin","year":"2003","journal-title":"Cell Res."},{"issue":"8","key":"10.1016\/j.peptides.2020.170402_bib0625","doi-asserted-by":"crossref","first-page":"5472","DOI":"10.1074\/jbc.275.8.5472","article-title":"Identification of the peptide-binding site in the heat shock chaperone\/tumor rejection antigen gp96 (Grp94)","volume":"275","author":"Linderoth","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.peptides.2020.170402_bib0630","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1021\/acscentsci.0c00272","article-title":"Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases","volume":"6","author":"Liu","year":"2020","journal-title":"ACS Cent. Sci."},{"issue":"38","key":"10.1016\/j.peptides.2020.170402_bib0635","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.3748\/wjg.v22.i38.8489","article-title":"Elucidation of the early infection machinery of hepatitis B virus by using bio-nanocapsule","volume":"22","author":"Liu","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"15","key":"10.1016\/j.peptides.2020.170402_bib0640","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1007\/s11434-007-0303-0","article-title":"Analysis of proteins that interact with nucleocapsid protein of SARS-CoV using 15-mer phage-displayed library","volume":"52","author":"Liu","year":"2007","journal-title":"Chin. Sci. Bull."},{"issue":"3","key":"10.1016\/j.peptides.2020.170402_bib0645","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jhep.2016.05.016","article-title":"Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B","volume":"65","author":"Lok","year":"2016","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.peptides.2020.170402_bib0650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076876","article-title":"Inhibition of influenza a virus infection in vitro by peptides designed in silico","volume":"8","author":"Lopez-Martinez","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.peptides.2020.170402_bib0655","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tips.2013.11.006","article-title":"Current progress in antiviral strategies","volume":"35","author":"Lou","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib0660","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bios.2011.11.008","article-title":"Sensing HIV related protein using epitope imprinted hydrophilic polymer coated quartz crystal microbalance","volume":"31","author":"Lu","year":"2012","journal-title":"Biosens. Bioelectron."},{"issue":"10","key":"10.1016\/j.peptides.2020.170402_bib0665","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.febslet.2005.02.070","article-title":"Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential","volume":"579","author":"Lu","year":"2005","journal-title":"FEBS Lett."},{"issue":"194","key":"10.1016\/j.peptides.2020.170402_bib0670","article-title":"antimicrobial peptides: an emerging category of therapeutic agents","volume":"6","author":"Mahlapuu","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"6","key":"10.1016\/j.peptides.2020.170402_bib0675","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1021\/acs.chemrev.9b00472","article-title":"Peptide-based vaccines: current progress and future challenges","volume":"120","author":"Malonis","year":"2020","journal-title":"Chem. Rev."},{"issue":"2","key":"10.1016\/j.peptides.2020.170402_bib0680","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41428-019-0252-x","article-title":"Detection of influenza virus by agglutination using nanoparticles conjugated with a sialic acid-mimic peptide","volume":"52","author":"Matsubara","year":"2020","journal-title":"Polym. J."},{"issue":"11","key":"10.1016\/j.peptides.2020.170402_bib0685","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1021\/jm1002183","article-title":"Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy","volume":"53","author":"Matsubara","year":"2010","journal-title":"J. Med. Chem."},{"issue":"32","key":"10.1016\/j.peptides.2020.170402_bib0690","doi-asserted-by":"crossref","first-page":"8981","DOI":"10.1073\/pnas.1603609113","article-title":"Highly sensitive detection of influenza virus by boron-doped diamond electrode terminated with sialic acid-mimic peptide","volume":"113","author":"Matsubara","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.peptides.2020.170402_bib0695","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.coph.2008.06.002","article-title":"Discovering and improving novel peptide therapeutics","volume":"8","author":"McGregor","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"issue":"3-4","key":"10.1016\/j.peptides.2020.170402_bib0700","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/biol.2001.0298","article-title":"Synthetic peptide vaccines: unexpected fulfillment of discarded hope?","volume":"29","author":"Meloen","year":"2001","journal-title":"Biologicals"},{"issue":"12","key":"10.1016\/j.peptides.2020.170402_bib0705","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1002\/jps.24174","article-title":"Pharmacokinetics of sifuvirtide in treatment-naive and treatment-experienced HIV-infected patients","volume":"103","author":"Meng","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib0710","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00430-014-0381-y","article-title":"Therapeutic vaccines in treating chronic hepatitis B: the end of the beginning or the beginning of the end?","volume":"204","author":"Michel","year":"2015","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.peptides.2020.170402_bib0715","series-title":"Moderna Announces Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273) Begins","author":"Moderna","year":"2020"},{"issue":"5","key":"10.1016\/j.peptides.2020.170402_bib0720","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","article-title":"Antimicrobial host defence peptides: functions and clinical potential","volume":"19","author":"Mookherjee","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.peptides.2020.170402_bib0725","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.virol.2010.03.007","article-title":"An optimally constrained V3 peptide is a better immunogen than its linear homolog or HIV-1 gp120","volume":"401","author":"Moseri","year":"2010","journal-title":"Virology"},{"issue":"28","key":"10.1016\/j.peptides.2020.170402_bib0730","doi-asserted-by":"crossref","first-page":"7780","DOI":"10.1039\/C5OB00449G","article-title":"Hepatitis B virus peptide inhibitors: solution structures and interactions with the viral capsid","volume":"13","author":"Muhamad","year":"2015","journal-title":"Org. Biomol. Chem."},{"issue":"3","key":"10.1016\/j.peptides.2020.170402_bib0735","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1128\/AAC.01211-08","article-title":"SC29EK, a peptide fusion inhibitor with enhanced alpha-helicity, inhibits replication of human immunodeficiency virus type 1 mutants resistant to enfuvirtide","volume":"53","author":"Naito","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.peptides.2020.170402_bib0740","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1128\/JVI.02528-09","article-title":"The pre-s2 domain of the hepatitis B virus is dispensable for infectivity but serves a spacer function for L-protein-connected virus assembly","volume":"84","author":"Ni","year":"2010","journal-title":"J. Virol."},{"issue":"Pt 5","key":"10.1016\/j.peptides.2020.170402_bib0745","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1099\/vir.0.038679-0","article-title":"a novel family of peptides with potent activity against influenza a viruses","volume":"93","author":"Nicol","year":"2012","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib0750","article-title":"Serological evidence of Bat SARS-related coronavirus infection in humans, China","volume":"33","author":"Ning Wang","year":"2018","journal-title":"Virol. Sin."},{"key":"10.1016\/j.peptides.2020.170402_bib0755","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3389\/fimmu.2019.01366","article-title":"Peptide antiviral strategies as an alternative to treat lower respiratory viral infections","volume":"10","author":"Nyanguile","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.peptides.2020.170402_bib0760","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1128\/JCM.41.5.2153-2155.2003","article-title":"Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy","volume":"41","author":"O\u2019Connell","year":"2003","journal-title":"J. Clin. Microbiol."},{"issue":"120","key":"10.1016\/j.peptides.2020.170402_bib0765","first-page":"2","article-title":"Design of a recombinant hepatitis B vaccine based on stably binding HLA-I peptides","volume":"4","author":"Ondieki","year":"2015","journal-title":"J. Biomol. Res. Ther."},{"issue":"2","key":"10.1016\/j.peptides.2020.170402_bib0770","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/emboj\/17.2.544","article-title":"p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53","volume":"17","author":"Ori","year":"1998","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib0775","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.peptides.2020.170402_bib0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2018.04.011","article-title":"De Novo macrocyclic peptide inhibitors of hepatitis B virus cellular entry","volume":"25","author":"Passioura","year":"2018","journal-title":"Cell Chem. Biol."},{"issue":"9366","key":"10.1016\/j.peptides.2020.170402_bib0785","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0140-6736(03)13077-2","article-title":"Coronavirus as a possible cause of severe acute respiratory syndrome","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.peptides.2020.170402_bib0790","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s00018-011-0715-5","article-title":"Retrocyclins and their activity against HIV-1","volume":"68","author":"Penberthy","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.peptides.2020.170402_bib0795","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nbt1389","article-title":"Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein","volume":"26","author":"Petersen","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.peptides.2020.170402_bib0800","series-title":"Pfizer. Pfizer and BioNTech Announce Early Positive Update from German Phase 1\/2 Covid-19 Vaccine Study, Including First T Cell Response Data","year":"2020"},{"key":"10.1016\/j.peptides.2020.170402_bib0805","series-title":"Pfizer. Pfizer And BioNTech Choose Lead mRNA Vaccine Candidate Against Covid-19 and Commence Pivotal Phase 2\/3 Global Study","year":"2020"},{"issue":"12","key":"10.1016\/j.peptides.2020.170402_bib0810","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/508748","article-title":"Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand","volume":"194","author":"Pitisuttithum","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.peptides.2020.170402_bib0815","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41541-020-0174-9","article-title":"Efficacy of FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb human influenza challenge study","volume":"5","author":"Pleguezuelos","year":"2020","journal-title":"NPJ Vaccines"},{"issue":"31","key":"10.1016\/j.peptides.2020.170402_bib0820","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1016\/j.vaccine.2012.04.089","article-title":"Synthetic influenza vaccine (FLU-v) stimulates cell mediated immunity in a double-blind, randomised, placebo-controlled phase I trial","volume":"30","author":"Pleguezuelos","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib0825","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/viro.1996.8367","article-title":"Both pre-S1 and S domains of hepatitis B virus envelope proteins interact with the core particle","volume":"228","author":"Poisson","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.peptides.2020.170402_bib0830","series-title":"ProtParam Tool","author":"Portal","year":"2020"},{"issue":"20","key":"10.1016\/j.peptides.2020.170402_bib0835","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa030634","article-title":"Identification of severe acute respiratory syndrome in Canada","volume":"348","author":"Poutanen","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.peptides.2020.170402_bib0840","series-title":"ANTIGENpro","author":"Predictor","year":"2020"},{"issue":"8","key":"10.1016\/j.peptides.2020.170402_bib0845","doi-asserted-by":"crossref","DOI":"10.3390\/v11080705","article-title":"Development of protein- and peptide-based HIV entry inhibitors targeting gp120 or gp41","volume":"11","author":"Pu","year":"2019","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.peptides.2020.170402_bib0850","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1099\/jgv.0.001289","article-title":"A peptide-based inhibitor of gp96 suppresses HBsAg expression and HBV replication by upregulation of p53","volume":"100","author":"Qian","year":"2019","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.peptides.2020.170402_bib0855","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1039\/C8BM01134F","article-title":"A hepatitis B virus-derived human hepatic cellspecific heparin-binding peptide: identification and application to a drug delivery system","volume":"7","author":"Qiushi Liu","year":"2019","journal-title":"Biomater. Sci."},{"issue":"26","key":"10.1016\/j.peptides.2020.170402_bib0860","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","author":"Laskowski MWM","year":"1993","journal-title":"J. Appl. Crystallogr."},{"issue":"3","key":"10.1016\/j.peptides.2020.170402_bib0865","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1021\/acs.molpharmaceut.7b01004","article-title":"Pharmacokinetic and chemical synthesis optimization of a potent d-peptide HIV entry inhibitor suitable for extended-release delivery","volume":"15","author":"Redman","year":"2018","journal-title":"Mol. Pharm."},{"issue":"23","key":"10.1016\/j.peptides.2020.170402_bib0870","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.peptides.2020.170402_bib0875","series-title":"MHC-II Binding Predictions","author":"Resource","year":"2020"},{"issue":"2","key":"10.1016\/j.peptides.2020.170402_bib0880","first-page":"133","article-title":"The laboratory diagnosis of severe acute respiratory syndrome: emerging laboratory tests for an emerging pathogen","volume":"25","author":"Richardson","year":"2004","journal-title":"Clin. Biochem. Rev."},{"issue":"4","key":"10.1016\/j.peptides.2020.170402_bib0885","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/aid.2017.0250","article-title":"Optimization of the EC26-2A4 epitope in the gp41 membrane proximal external region targeted by neutralizing antibodies from an elite controller","volume":"34","author":"Ringel","year":"2018","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib0890","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210965","article-title":"Re-boost immunizations with the peptide-based therapeutic HIV vaccine, vacc-4x, restores geometric mean viral load set-point during treatment interruption","volume":"14","author":"Rockstroh","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2020.170402_bib0895","article-title":"Substrate specificity profiling of SARS-CoV-2 main protease enables design of activity-based probes for patient-sample imaging","author":"Rut","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.peptides.2020.170402_bib0900","article-title":"Activity profiling and structures of inhibitor-bound SARS-CoV-2-PLpro protease provides a framework for anti-COVID-19 drug design","author":"Rut","year":"2020","journal-title":"bioRxiv"},{"issue":"Web Server issue","key":"10.1016\/j.peptides.2020.170402_bib0905","doi-asserted-by":"crossref","first-page":"W202","DOI":"10.1093\/nar\/gkl343","article-title":"AlgPred: prediction of allergenic proteins and mapping of IgE epitopes","volume":"34","author":"Saha","year":"2006","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib0910","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Prediction of continuous B-cell epitopes in an antigen using recurrent neural network","volume":"65","author":"Saha","year":"2006","journal-title":"Proteins"},{"issue":"2","key":"10.1016\/j.peptides.2020.170402_bib0915","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1021\/bc9003712","article-title":"Detection of HIV-1 specific monoclonal antibodies using enhancement of dye-labeled antigenic peptides","volume":"21","author":"Sapsford","year":"2010","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib0920","doi-asserted-by":"crossref","first-page":"10593","DOI":"10.1038\/s41598-017-10492-x","article-title":"Lactoferrin-derived peptides active towards influenza: identification of three potent tetrapeptide inhibitors","volume":"7","author":"Scala","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.peptides.2020.170402_bib0925","unstructured":"server Pd. http:\/\/db.systemsbiology.net:8080\/proteomicsToolkit\/proteinDigest.html."},{"key":"10.1016\/j.peptides.2020.170402_bib0930","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.8259","article-title":"Interpreting diagnostic tests for SARS-CoV-2","author":"Sethuraman","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.peptides.2020.170402_bib0935","doi-asserted-by":"crossref","first-page":"26","DOI":"10.32607\/20758251-2009-1-2-26-32","article-title":"Influenza virus neuraminidase: structure and function","volume":"1","author":"Shtyrya","year":"2009","journal-title":"Acta Nat."},{"issue":"9","key":"10.1016\/j.peptides.2020.170402_bib0940","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1021\/acsinfecdis.5b00089","article-title":"Screening of FDA-approved drugs for treatment of emerging pathogens","volume":"1","author":"Sisk","year":"2015","journal-title":"ACS Infect. Dis."},{"issue":"3","key":"10.1016\/j.peptides.2020.170402_bib0945","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrmicro775","article-title":"SARS--beginning to understand a new virus","volume":"1","author":"Stadler","year":"2003","journal-title":"Nat. Rev. Microbiol."},{"issue":"9","key":"10.1016\/j.peptides.2020.170402_bib0950","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1002\/eji.200737254","article-title":"Synthetic multi-epitope peptides identified in silico induce protective immunity against multiple influenza serotypes","volume":"37","author":"Stoloff","year":"2007","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.peptides.2020.170402_bib0955","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jinf.2017.09.004","article-title":"Sequential vacc-4x and romidepsin during combination antiretroviral therapy (cART): immune responses to vacc-4x regions on p24 and changes in HIV reservoirs","volume":"75","author":"Tapia","year":"2017","journal-title":"J. Infect."},{"issue":"3","key":"10.1016\/j.peptides.2020.170402_bib0960","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/hep.510290321","article-title":"Efficacy of lamivudine in patients with hepatitis B e antigen-negative\/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. lamivudine precore mutant study group","volume":"29","author":"Tassopoulos","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.peptides.2020.170402_bib0965","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"35","key":"10.1016\/j.peptides.2020.170402_bib0970","doi-asserted-by":"crossref","first-page":"7447","DOI":"10.1021\/bi200417k","article-title":"Investigating endogenous peptides and peptidases using peptidomics","volume":"50","author":"Tinoco","year":"2011","journal-title":"Biochemistry"},{"issue":"6037","key":"10.1016\/j.peptides.2020.170402_bib0975","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/317489a0","article-title":"The hepatitis B virus","volume":"317","author":"Tiollais","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2020.170402_bib0980","unstructured":"ToxinPred. https:\/\/webs.iiitd.edu.in\/raghava\/toxinpred\/index.html."},{"issue":"4","key":"10.1016\/j.peptides.2020.170402_bib0985","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124706","article-title":"Antiviral activity of the human cathelicidin, LL-37, and derived peptides on seasonal and pandemic influenza a viruses","volume":"10","author":"Tripathi","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.peptides.2020.170402_bib0990","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035421","article-title":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus","volume":"7","author":"Tseng","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2020.170402_bib0995","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejpb.2016.03.031","article-title":"A liposomal formulation for the oral application of the investigational hepatitis B drug myrcludex B","volume":"103","author":"Uhl","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.peptides.2020.170402_bib1000","series-title":"AIDS Data","year":"2020"},{"key":"10.1016\/j.peptides.2020.170402_bib1005","unstructured":"v2.0 T. http:\/\/www.cbs.dtu.dk\/services\/TMHMM\/."},{"issue":"4","key":"10.1016\/j.peptides.2020.170402_bib1010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/v8040096","article-title":"Current approaches for diagnosis of influenza virus infections in humans","volume":"8","author":"Vemula","year":"2016","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.peptides.2020.170402_bib1015","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jhep.2012.12.008","article-title":"The entry inhibitor myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus","volume":"58","author":"Volz","year":"2013","journal-title":"J. Hepatol."},{"issue":"28","key":"10.1016\/j.peptides.2020.170402_bib1020","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1002\/anie.201208344","article-title":"Nonproteinogenic amino acid building blocks for nonribosomal peptide and hybrid polyketide scaffolds","volume":"52","author":"Walsh","year":"2013","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.peptides.2020.170402_bib1025","first-page":"93","article-title":"Natural antimicrobial peptides as promising anti-HIV candidates","volume":"13","author":"Wang","year":"2012","journal-title":"Curr. Top. Pept. Protein Res."},{"issue":"8","key":"10.1016\/j.peptides.2020.170402_bib1030","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.tim.2016.06.007","article-title":"HBV slow maturation process leads to infection","volume":"24","author":"Watashi","year":"2016","journal-title":"Trends Microbiol."},{"issue":"5","key":"10.1016\/j.peptides.2020.170402_bib1035","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/hep.26982","article-title":"Cyclosporin a and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)","volume":"59","author":"Watashi","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.peptides.2020.170402_bib1040","unstructured":"WHO. (https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/hepatitis-b) 2015."},{"key":"10.1016\/j.peptides.2020.170402_bib1045","unstructured":"WHO. Hepatitis B, https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/hepatitis-b#:-:text=Hepatitis%20B%20is%20a%20potentially%20life-threatening%20liver%20infection,risk%20of%20death%20from%20cirrhosis%20and%20liver%20cancer; 2020."},{"issue":"Web Server issue","key":"10.1016\/j.peptides.2020.170402_bib1050","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"21","key":"10.1016\/j.peptides.2020.170402_bib1055","doi-asserted-by":"crossref","first-page":"10537","DOI":"10.1073\/pnas.89.21.10537","article-title":"A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition","volume":"89","author":"Wild","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.peptides.2020.170402_bib1060","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/QAD.0000000000001861","article-title":"Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1-infected individuals","volume":"32","author":"Winckelmann","year":"2018","journal-title":"Aids"},{"issue":"6","key":"10.1016\/j.peptides.2020.170402_bib1065","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.peptides.2011.04.017","article-title":"Effects of cathelicidin and its fragments on three key enzymes of HIV-1","volume":"32","author":"Wong","year":"2011","journal-title":"Peptides"},{"issue":"9370","key":"10.1016\/j.peptides.2020.170402_bib1070","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/S0140-6736(03)13376-4","article-title":"A multicentre collaboration to investigate the cause of severe acute respiratory syndrome","volume":"361","author":"World Health Organization Multicentre Collaborative Network for Severe Acute Respiratory Syndrome D","year":"2003","journal-title":"Lancet"},{"issue":"6483","key":"10.1016\/j.peptides.2020.170402_bib1075","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.peptides.2020.170402_bib1080","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","article-title":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China","volume":"27","author":"Wu","year":"2020","journal-title":"Cell Host Microb."},{"issue":"2","key":"10.1016\/j.peptides.2020.170402_bib1085","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.canlet.2015.01.034","article-title":"Heat shock protein gp96 decreases p53 stability by regulating Mdm2 E3 ligase activity in liver cancer","volume":"359","author":"Wu","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.peptides.2020.170402_bib1090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12929-016-0223-x","article-title":"Advancement and applications of peptide phage display technology in biomedical science","volume":"23","author":"Wu","year":"2016","journal-title":"J. Biomed. Sci."},{"issue":"7798","key":"10.1016\/j.peptides.2020.170402_bib1095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"issue":"5371","key":"10.1016\/j.peptides.2020.170402_bib1100","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1126\/science.280.5371.1884","article-title":"The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens","volume":"280","author":"Wyatt","year":"1998","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.peptides.2020.170402_bib1105","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","article-title":"Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion","volume":"30","author":"Xia","year":"2020","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib1110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/AAC.00976-09","article-title":"An albumin-conjugated peptide exhibits potent anti-HIV activity and long in vivo half-life","volume":"54","author":"Xie","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib1115","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01839-16","article-title":"A helical short-peptide fusion inhibitor with highly potent activity against human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus","volume":"91","author":"Xiong","year":"2017","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.peptides.2020.170402_bib1120","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jhep.2013.05.003","article-title":"Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: experiences and findings","volume":"59","author":"Xu","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.peptides.2020.170402_bib1125","doi-asserted-by":"crossref","first-page":"29391","DOI":"10.1038\/srep29391","article-title":"Efficient inhibition of hepatitis B virus infection by a preS1-binding peptide","volume":"6","author":"Ye","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.peptides.2020.170402_bib1130","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.peptides.2015.07.013","article-title":"Bioactive peptides derived from natural proteins with respect to diversity of their receptors and physiological effects","volume":"72","author":"Yoshikawa","year":"2015","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.peptides.2020.170402_bib1135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/v5010127","article-title":"Approaches for identification of HIV-1 entry inhibitors targeting gp41 pocket","volume":"5","author":"Yu","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.peptides.2020.170402_bib1140","article-title":"The first-in-class peptide binder to the SARS-CoV-2 spike protein","author":"Zhang","year":"2020","journal-title":"bioRxiv"},{"issue":"2","key":"10.1016\/j.peptides.2020.170402_bib1145","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/gutjnl-2018-317725","article-title":"A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice","volume":"69","author":"Zhang","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.peptides.2020.170402_bib1150","article-title":"A broad-spectrum virus- and host-targeting antiviral peptide against SARS-CoV-2 and other respiratory viruses","author":"Zhao","year":"2020","journal-title":"Nat. Res."},{"key":"10.1016\/j.peptides.2020.170402_bib1155","doi-asserted-by":"crossref","first-page":"22008","DOI":"10.1038\/srep22008","article-title":"A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses","volume":"6","author":"Zhao","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.peptides.2020.170402_bib1160","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/135965350501000301","article-title":"Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus","volume":"10","author":"Zheng","year":"2005","journal-title":"Antivir. Ther."},{"issue":"2","key":"10.1016\/j.peptides.2020.170402_bib1165","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0042-6822(03)00152-1","article-title":"The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA","volume":"310","author":"Zhou","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.peptides.2020.170402_bib1170","doi-asserted-by":"crossref","first-page":"13028","DOI":"10.1038\/srep13028","article-title":"Improved pharmacological and structural properties of HIV fusion inhibitor AP3 over enfuvirtide: highlighting advantages of artificial peptide strategy","volume":"5","author":"Zhu","year":"2015","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.peptides.2020.170402_bib1175","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses - drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978120301510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978120301510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:27:50Z","timestamp":1759310870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978120301510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":235,"alternative-id":["S0196978120301510"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2020.170402","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peptides to combat viral infectious diseases","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2020.170402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"170402"}}